Research on Optimizing the Use of Technology With Education
ROUTE-T1D
Optimizing Technology Uptake and Use in Hard to Reach Adolescents With Type 1 Diabetes
1 other identifier
interventional
60
1 country
1
Brief Summary
Consistent use of continuous glucose monitors (CGM) has the potential to improve glycemic control and related type 1 diabetes (T1D) health outcomes, however young adolescents with T1D are the least likely age group to begin and sustain use of CGM. The proposed study will conduct a feasibility trial of a behavioral intervention designed to optimize use of CGM in adolescents specifically targeting underrepresented populations in diabetes technology research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 26, 2022
CompletedFirst Posted
Study publicly available on registry
October 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedJuly 3, 2025
July 1, 2025
3 years
August 26, 2022
July 1, 2025
Conditions
Outcome Measures
Primary Outcomes (8)
Glycemic control
hemoglobin A1c (HbA1c)
Baseline
Glycemic control
hemoglobin A1c (HbA1c)
3 months post randomization
Glycemic control
hemoglobin A1c (HbA1c)
6 months post randomization
Glycemic control
hemoglobin A1c (HbA1c)
12 months post randomization
glycemic variability
Using 14-30 days of CGM data
Baseline
glycemic variability
Using 14-30 days of CGM data
3 months post randomization
glycemic variability
Using 14-30 days of CGM data
6 months post randomization
glycemic variability
Using 14-30 days of CGM data
12 months post randomization
Secondary Outcomes (20)
Family Conflict
Baseline
Family Conflict
3 months post randomization
Family Conflict
6 months post randomization
Family Conflict
12 months post randomization
Diabetes Distress
Baseline
- +15 more secondary outcomes
Study Arms (2)
Immediate intervention
EXPERIMENTALParticipants randomized to the immediate intervention group will participate in 3 video-conferencing sessions with a Certified Diabetes Care and Education Specialist (CDCES) interventionist and connect with a peer parent consultant immediately post randomization (expected intervention duration: 3 months).
Wait-list/delayed intervention
ACTIVE COMPARATORParticipants randomized to the delayed intervention group will receive no intervention for 6 months post-randomization; after the 6-month follow-up period, the delayed intervention group also will participate in 3 video conferencing sessions with a CDCES interventionist and connect with a peer parent consultant (expected intervention duration: 3 months).
Interventions
Intervention sessions will include parent/child discussion about barriers to CGM use, review of CGM data, problem solving, and working as a team.
Eligibility Criteria
You may qualify if:
- years old
- Type 1 diabetes
- Type 1 diabetes diagnosis ≥ 6 months \\
- Starting a continuous glucose monitor for the first time or restarting after ≥ 1 year
You may not qualify if:
- Younger than 10, older than 15
- Diagnosed less than 6 months
- Already using CGM or has used within last year
- Other major medical condition such as cancer, cystic fibrosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's National Research Institute
Washington D.C., District of Columbia, 20010, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Randi Streisand, PhD
Children's National Hosptial
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- a research assistant blind to condition of participant will complete outcome assessments.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Psych/Behavioral Hlth
Study Record Dates
First Submitted
August 26, 2022
First Posted
October 3, 2022
Study Start
January 1, 2022
Primary Completion
January 1, 2025
Study Completion (Estimated)
December 1, 2026
Last Updated
July 3, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share